Boston University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston University sits in the top decile of US sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count).
Boston University: 185 sponsored US clinical trials, 23 recruiting.
Boston University sponsors 185 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 125 completed. 12 of these trials are in Phase 3-4 (later-stage) and 35 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 3 trials.
Top-decile sponsor footprint
Boston University ranks in the top decile of sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
125 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
185 total, page 3 of 4
Written Exposure Therapy for Posttraumatic Stress Disorder
NCT01800773
Neurobiology of the Scalp in Seborrheic Dermatitis
NCT02349854
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
NCT01881347
Effect of Concord Grape Juice on Endothelial Function
NCT01775748
DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules
NCT01785342
Transcranial Magnetic Stimulation in Major Depression With EEG and Near Infrared Spectroscopy (NIRS) Monitoring
NCT01192685
China Adherence Through Technology Study
NCT01722552
A Brief Intervention
NCT01632176
Safety and Effect of Doxycycline in Patients With Amyloidosis
NCT01677286
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
NCT01636063
Pilot Study of the Effects of Erythritol on Endothelial Function in Patients With Type 2 Diabetes Mellitus
NCT01609088
Evaluating Vitamin D Content in Mushrooms
NCT01815437
Quantitative EEG Assessment of Cue-Induced Changes in Brain Activity in Alcohol Use Disorders
NCT01507909
IL1-TRAP, Rilonacept, in Systemic Sclerosis
NCT01538719
The Avoiding Diabetes Thru Action Plan Targeting Pilot Randomized Control Trial
NCT01473654
Communicating Risk Information for Obesity
NCT01355224
Minority AIDS Initiative Retention and Re-Engagement Project
NCT01616940
Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents
NCT01651611
Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction
NCT02133352
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
NCT01436279
Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion
NCT01436266
Same-day Long-acting Reversible Contraception for Medication Abortion
NCT01356927
Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery
NCT01910792
Fresolimumab In Systemic Sclerosis
NCT01284322
Tooth Smart Healthy Start: Oral Health Advocates in Public Housing
NCT01205971
Cognitive Control Training for Depression
NCT01454141
Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus
NCT01038089
Medications for Chronic HIV: Education and Collaboration
NCT01038076
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
NCT00986921
Effectiveness of an Internet-Based Self-Management Program in Treating Prolonged Grief Disorder
NCT00598884
Effect of Ile-Pro-Pro (IPP) on Endothelial Function in Patients With Coronary Artery Disease
NCT00924157
The Effect Of Vitamin D On Measures Of Bone Health And Gene Expression
NCT01696409
Effects of Almonds On Endothelial Function In Patients With Coronary Artery Disease
NCT01038362
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
NCT00855842
Dose-dependent Anti-inflammatory Effects of Vitamin D in a Human Gingivitis Model
NCT00779909
ROS Signaling in Endothelial Function
NCT01037465
Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder
NCT00862498
Study of Fish Oil to Reduce ALT Levels in Adolescents
NCT00694746
Effect of Salsalate on Bed Rest-Induced Vascular Dysfunction
NCT00553995
Efficacy of a Post-Rehabilitation Exercise Intervention
NCT00592813
Trial of Realignment Therapy for Treatment of Medial Knee Osteoarthritis
NCT00124462
Effect of Cranberry Juice on Endothelial Function
NCT00553904
New Therapy of Laryngeal Papilloma In Children
NCT00591305
Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function
NCT00554242
Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa
NCT00494858
Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence
NCT00545623
MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure
NCT00468299
A Pilot Study of Priming Before Induction Termination of Pregnancy
NCT00495560
Availability of Vitamin D in Orange Juice
NCT01778114
Knee Bracing for People With Patellofemoral Osteoarthritis
NCT00381563
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 19 |
| Phase 2 | 16 |
| Phase 3 | 4 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Boston University pipeline
23 recruiting of 185 indexed (12% open); 125 completed (68%).
Phase mix: 12 late (III/IV) vs 35 early (I/II) (early-phase heavy).
Top condition: HIV Infections (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston University: open-pipeline peers nationwide
Peers matched on 185 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 185 trials (± recruiting share)
- National Human Genome Research Institute (NHGRI) · 185 trials · 16% recruiting
- Children's Mercy Hospital Kansas City · 184 trials · 11% recruiting
- Arizona State University · 187 trials · 15% recruiting
- Johns Hopkins Bloomberg School of Public Health · 187 trials · 14% recruiting
Sponsors near 12% open enrollment (± trial volume)
- AstraZeneca · 12% recruiting · 1,285 trials
- National Heart, Lung, and Blood Institute (NHLBI) · 12% recruiting · 501 trials
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
Related
What to do with this Boston University page
185 registered trials is a research-attention snapshot, not an endorsement of Boston University or any single study.
- 23 of Boston University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition Boston University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Boston University pipeline card: 185 registered trials from official public datasets.Report a data error.